Berberine

Berberine

SCHEMBL2874125

COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.O.O.[Cl-]

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Berberine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE known ✓ P22303 10/20 0.98
▸ CHRM1 known ✓ P11229 2/20 0.98
▸ DRD2 known ✓ P14416 2/20 0.98
▸ ADRA2B known ✓ P18089 2/20 0.98
▸ ADRA2C known ✓ P18825 2/20 0.98
▸ HTR2B known ✓ P41595 2/20 0.98
▸ SIGMAR1 known ✓ Q99720 2/20 0.98
▸ MEN1 known ✓ O00255 1/20 0.96
▸ PPARD known ✓ Q03181 1/20 0.96
▸ BCHE P06276 8/20 0.98
▸ EP300 Q09472 7/20 0.98
▸ CYP3A4 P08684 4/20 0.98
▸ MAPT P10636 4/20 0.98
▸ RAD52 P43351 4/20 0.98
▸ LMNA P02545 3/20 0.98
▸ CYP2D6 P10635 3/20 0.98
▸ ALDH1A1 P00352 2/20 0.98
▸ TSHR P16473 2/20 0.98
▸ RXRA P19793 2/20 0.98
▸ DRD1 P21728 2/20 0.98

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Berberine SCHEMBL30420905 1.00 ACHE (0.98) ACHEBCHEEP300CYP3A4MAPT
Berberine SCHEMBL1373393 1.00 ACHE (0.98) ACHEBCHEEP300CYP3A4MAPT
Berberine SCHEMBL30833079 1.00 ACHE (0.98) ACHEBCHEEP300CYP3A4MAPT
Berberine SCHEMBL29749148 0.99 ACHE (1.00) ACHEBCHEEP300CYP3A4MAPT
Berberine SCHEMBL15936397 0.99 ACHE (0.98) ACHEBCHEEP300CYP3A4MAPT
Berberine SCHEMBL29396036 0.99 ACHE (1.00) ACHEBCHEEP300CYP3A4MAPT
Berberine SCHEMBL153906 0.99 ACHE (1.00) ACHEBCHEEP300CYP3A4MAPT
Berberine SCHEMBL25632 0.98 ACHE (1.00) ACHEBCHEEP300CYP3A4MAPT
Berberine SCHEMBL30153843 0.98 ACHE (1.00) ACHEBCHEEP300CYP3A4MAPT
Berberine SCHEMBL15669190 0.98 ACHE (1.00) ACHEBCHEEP300CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119391404-A Aggregation-induced emission glycyrrhizic acid nanoparticle and preparation method and application thereof 华南理工大学 2025-02-07 — — CN claimed
EP-2102654-B1 METHOD AND KIT FOR DETECTING HERBICIDE RESISTANCE IN PLANTS UNIV AARHUS (DK) 2014-08-13 — — EP claimed
US-20100150842-A1 Method and Kit for Detecting Resistance in Living Organisms AARHUS UNIVERSITET (DK) 2010-06-17 — — US claimed
EP-2102654-A1 METHOD AND KIT FOR DETECTING RESISTANCE IN LIVING ORGANISMS Aarhus Universitet (DK) 2009-09-23 — — EP claimed
WO-2008080410-A1 METHOD AND KIT FOR DETECTING RESISTANCE IN LIVING ORGANISMS AARHUS UNIVERSITET (DK) 2008-07-10 — — WO claimed
US-12358922-B1 Berberine alpha-ketoglutarate salt, crystalline form, methods of preparation and applications thereof LONGEVITAN BIOSCIENCES LLC (US) 2025-07-15 — — US disclosed
CN-119391404-A Aggregation-induced emission glycyrrhizic acid nanoparticle and preparation method and application thereof 华南理工大学 2025-02-07 — — CN disclosed
CN-118695854-A Food-related particles, production method and production device 努利希尔有限公司 2024-09-24 — — CN disclosed
EP-4401711-A1 STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2024-07-24 — — EP disclosed
EP-4401713-A1 ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS Nulixir Inc. (US) 2024-07-24 — — EP disclosed
EP-4401714-A1 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2024-07-24 — — EP disclosed
EP-4401712-A1 ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2024-07-24 — — EP disclosed
EP-2102653-B1 METHOD AND KIT FOR TESTING WHETHER A SPECIFIC PLANT HAS BEEN EXPOSED TO A SPECIFIC PESTICIDE UNIV AARHUS (DK) 2014-08-13 — — EP disclosed
EP-2102654-B1 METHOD AND KIT FOR DETECTING HERBICIDE RESISTANCE IN PLANTS UNIV AARHUS (DK) 2014-08-13 — — EP disclosed
US-20100150842-A1 Method and Kit for Detecting Resistance in Living Organisms AARHUS UNIVERSITET (DK) 2010-06-17 — — US disclosed
US-20100047176-A1 Method and Kit for Testing Stress Effects in Living Organisms AARHUS UNIVERSITET (DK) 2010-02-25 — — US disclosed
EP-2102654-A1 METHOD AND KIT FOR DETECTING RESISTANCE IN LIVING ORGANISMS Aarhus Universitet (DK) 2009-09-23 — — EP disclosed
EP-2102653-A1 A METHOD AND KIT FOR TESTING STRESS EFFECTS IN LIVING ORGANISM Aarhus Universitet (DK) 2009-09-23 — — EP disclosed
WO-2008080409-A1 A METHOD AND KIT FOR TESTING STRESS EFFECTS IN LIVING ORGANISM AARHUS UNIVERSITET (DK) 2008-07-10 — — WO disclosed
WO-2008080410-A1 METHOD AND KIT FOR DETECTING RESISTANCE IN LIVING ORGANISMS AARHUS UNIVERSITET (DK) 2008-07-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100047176-A1 Method and Kit for Testing Stress Effects in Living Organisms DDT, ACHE, WEE1 ACHE 2/4885CHRM1 1520/4885DRD2 1482/4885
US-12358922-B1 Berberine alpha-ketoglutarate salt, crystalline form, methods of preparation and applications thereof BCKDK, GLS, HOGA1 ACHE 3230/4885CHRM1 4491/4885DRD2 4878/4885
US-20100150842-A1 Method and Kit for Detecting Resistance in Living Organisms DDT, NOTUM, ACHE ACHE 3/4885CHRM1 1699/4885DRD2 2126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback